153 related articles for article (PubMed ID: 32788207)
21. USP7 inhibition inhibits proliferation and induces megakaryocytic differentiation in MDS cells by upregulating gelsolin.
Deng J; Liang L; Yi H; Su T; Yang Z; Nie L; Liu J
Br J Haematol; 2020 Aug; 190(3):418-429. PubMed ID: 32130729
[TBL] [Abstract][Full Text] [Related]
22. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
Peng Y; Liu Y; Gao Y; Yuan B; Qi X; Fu Y; Zhu Q; Cao T; Zhang S; Yin L; Li X
J Exp Clin Cancer Res; 2019 Nov; 38(1):468. PubMed ID: 31730000
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.
Carrà G; Panuzzo C; Torti D; Parvis G; Crivellaro S; Familiari U; Volante M; Morena D; Lingua MF; Brancaccio M; Guerrasio A; Pandolfi PP; Saglio G; Taulli R; Morotti A
Oncotarget; 2017 May; 8(22):35508-35522. PubMed ID: 28418900
[TBL] [Abstract][Full Text] [Related]
24. Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.
Gavory G; O'Dowd CR; Helm MD; Flasz J; Arkoudis E; Dossang A; Hughes C; Cassidy E; McClelland K; Odrzywol E; Page N; Barker O; Miel H; Harrison T
Nat Chem Biol; 2018 Feb; 14(2):118-125. PubMed ID: 29200206
[TBL] [Abstract][Full Text] [Related]
25. Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy.
Cheng YJ; Zhuang Z; Miao YL; Song SS; Bao XB; Yang CH; He JX
Biochem Pharmacol; 2024 Apr; 222():116071. PubMed ID: 38387527
[TBL] [Abstract][Full Text] [Related]
26. USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.
Pozhidaeva A; Valles G; Wang F; Wu J; Sterner DE; Nguyen P; Weinstock J; Kumar KGS; Kanyo J; Wright D; Bezsonova I
Cell Chem Biol; 2017 Dec; 24(12):1501-1512.e5. PubMed ID: 29056420
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity.
He Y; Li W; Lv D; Zhang X; Zhang X; Ortiz YT; Budamagunta V; Campisi J; Zheng G; Zhou D
Aging Cell; 2020 Mar; 19(3):e13117. PubMed ID: 32064756
[TBL] [Abstract][Full Text] [Related]
28. The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits.
Mitxitorena I; Somma D; Mitchell JP; Lepistö M; Tyrchan C; Smith EL; Kiely PA; Walden H; Keeshan K; Carmody RJ
J Biol Chem; 2020 Aug; 295(33):11754-11763. PubMed ID: 32587091
[TBL] [Abstract][Full Text] [Related]
29. Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60.
Wang F; Wang L; Wu J; Sokirniy I; Nguyen P; Bregnard T; Weinstock J; Mattern M; Bezsonova I; Hancock WW; Kumar S
PLoS One; 2017; 12(12):e0189744. PubMed ID: 29236775
[TBL] [Abstract][Full Text] [Related]
30. Discovery of USP7 small-molecule allosteric inhibitors.
Engström O; Belda O; Kullman-Magnusson M; Rapp M; Böhm K; Paul R; Henderson I; Derbyshire D; Karlström S; Parkes KEB; Zhao H
Bioorg Med Chem Lett; 2020 Oct; 30(20):127471. PubMed ID: 32781219
[TBL] [Abstract][Full Text] [Related]
31. CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.
Morra F; Merolla F; Criscuolo D; Insabato L; Giannella R; Ilardi G; Cerrato A; Visconti R; Staibano S; Celetti A
J Exp Clin Cancer Res; 2019 Feb; 38(1):90. PubMed ID: 30786932
[TBL] [Abstract][Full Text] [Related]
32. The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy.
Nininahazwe L; Liu B; He C; Zhang H; Chen ZS
Drug Discov Today; 2021 Feb; 26(2):490-502. PubMed ID: 33157193
[TBL] [Abstract][Full Text] [Related]
33. USP7 promotes cell proliferation through the stabilization of Ki-67 protein in non-small cell lung cancer cells.
Zhang C; Lu J; Zhang QW; Zhao W; Guo JH; Liu SL; Wu YL; Jiang B; Gao FH
Int J Biochem Cell Biol; 2016 Oct; 79():209-221. PubMed ID: 27590858
[TBL] [Abstract][Full Text] [Related]
34. Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects.
Yeasmin Khusbu F; Chen FZ; Chen HC
Cell Biochem Funct; 2018 Jul; 36(5):244-254. PubMed ID: 29781103
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy.
Cartel M; Mouchel PL; Gotanègre M; David L; Bertoli S; Mansat-De Mas V; Besson A; Sarry JE; Manenti S; Didier C
Leukemia; 2021 Feb; 35(2):417-432. PubMed ID: 32447346
[TBL] [Abstract][Full Text] [Related]
36. CDDO-Me reveals USP7 as a novel target in ovarian cancer cells.
Qin D; Wang W; Lei H; Luo H; Cai H; Tang C; Wu Y; Wang Y; Jin J; Xiao W; Wang T; Ma C; Xu H; Zhang J; Gao F; Wu YL
Oncotarget; 2016 Nov; 7(47):77096-77109. PubMed ID: 27780924
[TBL] [Abstract][Full Text] [Related]
37. Structural Basis of the Interaction Between Ubiquitin Specific Protease 7 and Enhancer of Zeste Homolog 2.
Gagarina V; Bojagora A; Lacdao IK; Luthra N; Pfoh R; Mohseni S; Chaharlangi D; Tan N; Saridakis V
J Mol Biol; 2020 Feb; 432(4):897-912. PubMed ID: 31866294
[TBL] [Abstract][Full Text] [Related]
38. USP7 limits CDK1 activity throughout the cell cycle.
Galarreta A; Valledor P; Ubieto-Capella P; Lafarga V; Zarzuela E; Muñoz J; Malumbres M; Lecona E; Fernandez-Capetillo O
EMBO J; 2021 Jun; 40(11):e99692. PubMed ID: 33856059
[TBL] [Abstract][Full Text] [Related]
39. Identification and Characterization of USP7 Targets in Cancer Cells.
Georges A; Marcon E; Greenblatt J; Frappier L
Sci Rep; 2018 Oct; 8(1):15833. PubMed ID: 30367141
[TBL] [Abstract][Full Text] [Related]
40. Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies.
Wu J; Kumar S; Wang F; Wang H; Chen L; Arsenault P; Mattern M; Weinstock J
J Med Chem; 2018 Jan; 61(2):422-443. PubMed ID: 28768102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
